In the case of medicinal products for human use, the criteria of quality, safety and efficacy have been extensively harmonized by ... the Second Council Directive 75/319/EEC of 20 May 1975 on the approximation of provisions laid down by law, regulation and administrative action relating to proprietary medicinal products.